ZA200808600B - Methods and compositions for the detection and treatment of cancers - Google Patents

Methods and compositions for the detection and treatment of cancers

Info

Publication number
ZA200808600B
ZA200808600B ZA200808600A ZA200808600A ZA200808600B ZA 200808600 B ZA200808600 B ZA 200808600B ZA 200808600 A ZA200808600 A ZA 200808600A ZA 200808600 A ZA200808600 A ZA 200808600A ZA 200808600 B ZA200808600 B ZA 200808600B
Authority
ZA
South Africa
Prior art keywords
cancers
compositions
detection
treatment
methods
Prior art date
Application number
ZA200808600A
Other languages
English (en)
Inventor
Vincent Piguet
Rocha Rafael Correa
Laurent Bracco
Original Assignee
Exonhit Therapeutics Sa
Hopitaux Universitaires De Gen
Univ Geneve
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Exonhit Therapeutics Sa, Hopitaux Universitaires De Gen, Univ Geneve filed Critical Exonhit Therapeutics Sa
Publication of ZA200808600B publication Critical patent/ZA200808600B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/5743—Specifically defined cancers of skin, e.g. melanoma
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA200808600A 2006-03-16 2008-10-08 Methods and compositions for the detection and treatment of cancers ZA200808600B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06290425A EP1835036A1 (en) 2006-03-16 2006-03-16 Methods and compositions for the detection and treatment of cancers

Publications (1)

Publication Number Publication Date
ZA200808600B true ZA200808600B (en) 2009-12-30

Family

ID=36525297

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200808600A ZA200808600B (en) 2006-03-16 2008-10-08 Methods and compositions for the detection and treatment of cancers

Country Status (9)

Country Link
US (1) US20090298766A1 (ja)
EP (2) EP1835036A1 (ja)
JP (1) JP2009529869A (ja)
KR (1) KR20090060212A (ja)
CN (1) CN101548020A (ja)
AU (1) AU2007226234A1 (ja)
CA (1) CA2646269A1 (ja)
WO (1) WO2007105114A2 (ja)
ZA (1) ZA200808600B (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2207894A2 (en) * 2007-10-12 2010-07-21 Decode Genetics EHF Sequence variants for inferring human pigmentation patterns
CN106636116B (zh) * 2015-07-31 2020-09-15 深圳市第二人民医院 基因突变序列及其在鉴定膀胱癌干细胞中的应用
EP3413237A1 (en) 2015-11-04 2018-12-12 Shutterfly, Inc. Automatic image product creation for user accounts comprising large number of images
CN107766696A (zh) * 2016-08-23 2018-03-06 武汉生命之美科技有限公司 基于RNA‑seq数据的真核生物可变剪接分析方法和系统

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861719A (en) 1986-04-25 1989-08-29 Fred Hutchinson Cancer Research Center DNA constructs for retrovirus packaging cell lines
US5278056A (en) 1988-02-05 1994-01-11 The Trustees Of Columbia University In The City Of New York Retroviral packaging cell lines and process of using same
US5670488A (en) 1992-12-03 1997-09-23 Genzyme Corporation Adenovirus vector for gene therapy
WO1994019478A1 (en) 1993-02-22 1994-09-01 The Rockefeller University Production of high titer helper-free retroviruses by transient transfection
FR2712812B1 (fr) 1993-11-23 1996-02-09 Centre Nat Rech Scient Composition pour la production de produits thérapeutiques in vivo.
IL116816A (en) 1995-01-20 2003-05-29 Rhone Poulenc Rorer Sa Cell for the production of a defective recombinant adenovirus or an adeno-associated virus and the various uses thereof
US6013516A (en) 1995-10-06 2000-01-11 The Salk Institute For Biological Studies Vector and method of use for nucleic acid delivery to non-dividing cells
WO2002010449A2 (en) * 2000-07-28 2002-02-07 Compugen Inc. Oligonucleotide library for detecting rna transcripts and splice variants that populate a transcriptome

Also Published As

Publication number Publication date
EP1835036A1 (en) 2007-09-19
WO2007105114A3 (en) 2008-03-13
CN101548020A (zh) 2009-09-30
JP2009529869A (ja) 2009-08-27
WO2007105114A8 (en) 2009-08-13
US20090298766A1 (en) 2009-12-03
AU2007226234A1 (en) 2007-09-20
CA2646269A1 (en) 2007-09-20
EP1996727A2 (en) 2008-12-03
KR20090060212A (ko) 2009-06-11
WO2007105114A2 (en) 2007-09-20

Similar Documents

Publication Publication Date Title
IL257681A (en) Methods and compositions for the treatment of cancer
EP1969147A4 (en) METHODS AND COMPOSITIONS BASED ON MICRO-RNA AND APPLYING TO THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS
EP2310526A4 (en) COMPOSITIONS FOR THE DETECTION AND TREATMENT OF COLORECTAL CANCER
ZA200904492B (en) Compositions and methods for the treatment of infections and tumors
HK1140944A1 (en) Methods and compositions for treating recurrent cancer
EP2361089A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALTERED FUNCTION OF -SYNUCLEINE
ZA200901615B (en) Compositions and methods for diagnosing and treating cancer
PL2032166T3 (pl) Kompozycje i sposoby diagnozowania i leczenia nowotworów
HK1148906A1 (en) Compositions and methods for cancer treatment
EP2049151A4 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT OF CANCER
HK1159498A1 (en) Methods and compositions for the treatment of cancer
WO2007081751A9 (en) Compositions and methods for the treatment of cancer
IL196843A0 (en) Compositions and methods for the treatment of radiation proctosigmoitis
EP2340027A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
HK1140019A1 (en) Compositions and methods of detection
HRP20130642T1 (en) Methods and compositions for treating cancers
EP2150270A4 (en) METHODS AND COMPOSITIONS FOR TREATING CANCER
EP2099491A4 (en) COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING CANCER
EP1904088A4 (en) COMPOSITIONS AND METHODS FOR TREATING CANCER
ZA200808600B (en) Methods and compositions for the detection and treatment of cancers
IL226363A0 (en) Compounds and methods for treating cancer
EP1926836A4 (en) COMPOSITIONS AND METHODS FOR DETECTING COLORECTAL CARCINOMA
IL201502A0 (en) Methods and compositions for contributing to the treatment of cancers
EP2068629A4 (en) COMPOSITIONS AND METHODS FOR TREATING CANCER
AU2008905198A0 (en) Compositions and Methods for the Prevention and Treatment of Cancer